Therapeutic Asset Ratings

Adrx-0706

ai-061

Alpaloritovorelli Antibodies

an0025

ASTX 660

Bl-M07D1

Crte7A2-01 Tcr-T Cell

Crte7A2-01 Tcr-T Cell Therapy

dr-0202

Drug Product De-Til-0255

Eloxatin

Emunkitug

H-gamma1 heavy chain humanized (1-449) [VH (Homo sapiens IGHV3-23*01 (81.6%) -(IGHD) -IGHJ3*02 (91.7%) M123>T (114), CDR-IMGT [8.7.13] (26-33.51-57.96-108)) (1-119) -Homo sapiens IGHG1*03v (100%) G1m3>G1m17, nG1m1 CH1 K120, CH3 E12, M14 (CH1 R120>K (216) (120-217), hinge 1-15 (218-232), CH2 (233-342), CH3 E12 (358), M14 (360) (343-447), CHS (448-449)) (120-449)], (222-218')-disulfide with L-kappa light chain humanized (1'-218') [VKAPPA (Homo sapiens IGKV1-33*01 (87.8%) -IGKJ4*01 (100%), CDR-IMGT [6.3.13] (27'-32'.50'-52'.89'-101')) (1'-111')-Homo sapiens IGKC*01 (100%) Km3 A45.1, V101 (C-KAPPAA45.1 (157'), V101 (195')) (112'-218')]; dimer (228-228'':231-231'')-bisdisulfide, produced in Chinese hamster ovary (CHO) cells, cell line CHO-K1, glycoform alfa

hh160

Hryz-T101

Hryz-T101 Tcr-T Cell

HUMAN FAECAL MATTER

Immunoglobulin G1 [de-448-lysine], anti-(human epidermal growth factor receptor) (human-mouse monoclonal C225 ?1-chain) fusion protein with peptide linker (GGGGS)2 fusion protein with immunoglobulin anti-(human epidermal growth factor receptor HER3) (human clone HER3.H3 single-chain variable fragment VH-(GGGGS)3-VL), complex with human-mouse monoclonal C225 ?-chain, dimer, 214??,214???,222,222?,228,228?,231,231?-octakis(thioether) with (2S)-N-(carboxymethyl)-2-(3-mercapto-2,5-dioxo-1-pyrrolidinyl)-?-alanylglycylglycyl-L-phenylalanyl-N-[[(1S)-2-[[(1S,9S)-9-ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12H-benzo[de]pyrano[3?,4?:6,7]indolizino[1,2-b]quinolin-1-yl]amino]-1-methyl-2-oxoethoxy]methyl]glycinamide

Itil-168

Kk-Lc-1 Tcr-T Cells

Loperamide

ly4052031

ly4101174

MGC026

mt-8421